Biocept, Inc., established in 1997 and based in San Diego, California, was a molecular oncology diagnostics firm. Its primary business involved the development and commercialization of exclusive clinical laboratory assays within the United States. These advanced tests were engineered to detect elusive tumor cells and cell-free tumor DNA (ctDNA) from both blood and cerebrospinal fluid (CSF) samples.